Top compounds associated with response to DDX20


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC 0.13 0.01
mRNA narciclasine CTRPv2 pan-cancer AAC 0.082 0.01
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.01
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 0.01
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.086 0.01
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.01
mRNA linifanib CTRPv2 pan-cancer AAC 0.088 0.01
mRNA RG-108 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.02
mRNA paclitaxel CCLE pan-cancer AAC 0.11 0.02
Download CSV